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knock down target genes in mammalian cells without triggering immune responses; [3] which 
was a very favorable outcome. RNAi can be artificially achieved in three ways: (i) Introducing 
plasmid DNA to the cell that encodes for short hairpin RNA (shRNA) which is cleaved to short 
(21-26 nucleotides) interfering RNA (siRNA) in the cell by the enzyme complex Dicer which 
contains endoribonuclease activity. The resulting siRNA will lead to the cleavage and 
degradation of the target mRNA. (ii) Introducing long double stranded RNA (dsRNA) which is 
endogenously processed inside the cell by Dicer to siRNA. (iii) Directly introducing synthetic 
siRNA to achieve mRNA degradation. The latter approach is of great interest and will be further 
discussed in this chapter. When siRNA is internalized in the cell, the double stranded siRNA 
binds to the RNA-induced silencing complex (RISC) and is unwound into two single strands; the 
sense and anti-sense strand. The sense strand is removed and degraded by nucleases. The anti-
sense strand directs the RISC to the complementary sequence of the mRNA to induce cleavage 






siRNA delivery: Introducing short interfering RNA 
(siRNA, 21-26 nucleotides) with a specific sequence to the 
cell in order to induce RNA interferenace (RNAi), and to 
silence a specific target gene. siRNA delivery is used to 
silence overexpressed genes in various diseases including 
lung diseases.   












 lung is pr
 to various 
such as tub
received spe
































































The second zone is the respiratory zone where the gas exchange occurs. It consists of the 
respiratory bronchioles and alveoli [7]. Pulmonary delivery of siRNA presents many advantages 
compared to the systemic route such as the localized effect on lung epithelial cells with lower 
administered doses of siRNA, reduced undesired systemic effects, and higher stability due to 
negligible nuclease activity in the lung compared to the blood stream. In addition, the lungs can 
function as a remarkable site of absorption for systemic effects with a rapid and effective 
delivery due to the large alveolar surface area with high vascularization and thin air-blood-
barrier.  Such advantages have promoted pulmonary delivery to be an attractive route of 
administration. However, pulmonary delivery also needs to overcome the barriers associated 
with many parts of the respiratory airways. Coughing and dissolution are important parts of the 
lung's defense against inhaled particles but can prove to be difficult barriers to overcome. The 
ciliated epithelial cells in the lung perform a rapid mucociliary clearance action to remove any 
deposited particles which are eventually swallowed or coughed out. The presence of the mucus 
layer and surfactant proteins is another barrier for uptake. In addition, macrophages present in 
the respiratory airways tend to phagocytose particles between 1 and 3 μm in size and to degrade 
them. Therefore, the lung possesses several anatomical, physiological, and physiochemical 
barriers that can be impaired or more prominent in a disease state and alter the efficiency of the 




Mucociliary clearance: a host defense clearing 
mechanism of the airways which is performed 
by coordinated cilia movement to clear particles 






For efficient siRNA delivery, a therapeutic agent is required to overcome those barriers 
and successfully reach the lower respiratory tract where the cell layer and the mucus layer are 
significantly thinner than in the upper airways. The site of the particle deposition in the lung 
depends on the size, expressed as aerodynamic diameter, of the administered particle as well as 
the patient’s pulmonary function [10-12]. Large particles with aerodynamic diameters larger than 
6 μm are usually deposited at the back of the pharynx or throat due to their high momentum. 
Thus, they are not suitable for the delivery to lower respiratory sites. Therefore, smaller droplet 
or particle sizes are required to maximize the siRNA deposition in the lung. However, particles 
smaller than 1 μm in aerodynamic diameter were believed to be exhaled during normal breathing 
as their movement is controlled by Brownian motion [10-12]. For efficient deposition in the 
lung, the optimal hydrodynamic diameter has been reported to range between 1 and 5 μm. Newer 
studies show that as the size of the particles decreases below 100nm, the diffusional mobility of 
the particles increases and hence their deposition in the lung increases. Nanoparticles (<100nm) 
can successfully reach and settle in the alveolar site with 55 % and higher fractional deposition 
depending on the particle diameter [13] and pulmonary function in healthy and asthmatic 
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the oligoribonucleotides which is pursued mainly to increase the nuclease resistance. In addition, 
chemical modification of siRNA is aimed to increase siRNA specificity and potency as well as to 
reduce the off-targeting and immune response without impairing the ability of siRNA to knock 
down the target gene [36, 37]. Chemically modified siRNA therapeutics succeeded in clinical 
trials. One example is Alynam's ALN-RSV-01 siRNA which is modified by cholesterol 
attachment to the sense strand. The second approach may also employ modified siRNA but 
additionally enhances the siRNA protection by using carrier systems which are divided into viral 
vectors and non-viral vectors. Viral vectors take advantage of the penetration ability of viruses 
through cellular membranes. Examples for viral vectors are retroviruses, adenoviruses, and 
lentiviruses which can transfect cells very effectively. However, they present some safety 
concerns such as toxicity, immunogenicity, tumorigenicity as well as uncontrolled virus 
replication [38]. Despite their toxicity, viral vectors are still considered in clinical trials due to 
their high transfection efficacy. In order to overcome these side effects, however, non-viral 




i. Lipid-based delivery vectors, such as liposomes and lipid particles. Positively-charged 
lipids, for example, can interact with negatively charged siRNA oligonucleotides by 
spontaneous electrostatic interaction to form lipoplexes. When aerosolized, lipoplexes may 
underdo structural changes that may lead to premature release of siRNA from the lipoplexes 
Non-viral vectors possess low host 
immunogenicity, however lower transfection 
efficiency compared to viruses. Various 
strategies are followed to design and develop 






[20, 39]. The drawbacks of these vectors are their toxicity and non-selective activation of 
immune response [40, 41]. Many of the commercially available siRNA transfection agents 
that are engaged in pulmonary delivery are lipid-based, such as lipofectamine® and 
oligofectamineTM. 
ii. Polymer-based delivery vectors, such as synthetic poly (lactic-co-glycolic acid) (PLGA), 
polyethylenimine (PEI), and natural chitosan. This class of vectors can easily be chemically 
modified to avoid the induction of immune responses. In addition polymer-based vectors are 
generally cheap, versatile and easy to modify to gain desirable characteristics such as 
biodegradability and cell- specific targeting effect [42-44]. Polymeric vectors can be further 
subdivided into polycations for electrostatic self-assembly and polymeric solid nanoparticles 
which encapsulate their load. Polycations react with negatively charged siRNA to form 
polyelectrolyte complexes, so called polyplexes. The main concern with polycations is their 
toxicity generated from their charge. Examples for polycations widely used for siRNA 
delivery are polyamide amine (PAMAM) dendrimers [45], PEI [24], and chitosan [46]. The 
characteristics of the delivery system depend on the charge ratio, molecular weight of the 
polymer and method of preparation [47]. Solid polymeric nanoparticles such as PLGA 
nanoparticles encapsulate siRNA. The siRNA can be encapsulated and dispersed completely 
in the nanoparticle core or surrounded by a polymeric shell.  
iii. Peptide transduction domains (PTDs) or cell-penetrating peptides are small positively 
charged molecules (10-30 amino acids). They usually contain arginine and lysine to provide 
positive charges which electrostatically interact with siRNA and enhance the permeability of 





A summary of non-viral vectors used in pulmonary siRNA delivery in vivo is presented in Table 
1.1. 
Table  1.1: Examples of in vivo studies of siRNA delivery systems in the lung grouped according 



















Naked siRNA HO-1 Intra-nasal C57BL/6 mice Unmodified 
siRNA 




RSV-P Intra-nasal BALB/c mice Unmodified 
siRNA 
Inhibition of RSV infection [49] 
SiRNA-
cy3 
Intra-nasal C57BL/6 mice Unmodified 
siRNA 
Low distribution of siRNA 
in lung  
[50] 
PAI-1 Intra-nasal C57BL/6 mice Unmodified 
siRNA 



















C57BL/6 mice Unmodified 
siRNA 
Significant reduction in 
expression of Fas and 






C57BL/6 mice Unmodified 
siRNA 
Suppression of XCL1 
mRNA and protein 




C57BL/6 mice Unmodified 
siRNA 
Suppression of mRNA 
expression of KC and MIP-
2 in lung by ~40% 
Reduction of IL-6 and 
MPO activity  
[55] 
siSC2-5 Intra-nasal Rhesus macaque Unmodified 
siRNA 
Diminished SARS 
coronavirus (SCV) levels 
in monkey respiratory tract 
Decreased acute diffuse 
alveoli damage 
[56] 
EHV-1 Intra-nasal BALB/c mice Unmodified 
siRNA 
significantly reduced viral 







Ang2 Intra-nasal C57BL/6 mice Naked siRNA Ang2 increases 
inflammation and cell 









C57BL/6 mice Modified siRNA High distribution of 
siRNA- cy3 in lung 
~21% knock down of E-
cadherin  but no significant 
reduction of endothelial 
VE-cadherin 
[50]  
Lipid RSV-P Intra-nasal BALB/c mice Lipid (TransIT-
TKO) 












siRNA compared to naked 
siRNA 
Lipoplex caused cellular 






BALB/c mice Lipid 
(cholesterol) 
Knock down effect not 
enhanced 
Extended duration of 









nude mice with 
orthotopic 




Higher peak concentrations 
Abundant longer retention 
of liposomes in the lungs 








C57BL/6 mice Lipid 
(DharmaFECT) 
SPARC siRNA significantl
y reduced gene and protein 
expression  
[61] 





Significant reduction in 
tumor foci  
Reduction in size and 
number of tumor blood 
vessels 
[62] 
EGFP Intra-nasal C57BL/6 mice Chitosan  Effective (~37%) EGFP 
knock down in bronchiole 
epithelial cells of mice 
[63] 






knockdown  of GAPDH 








 K-rasLA1 mice Poly(ester 
amine) 
Inhibition of Akt-related 
signals and cell cycle 
Significant suppression of 
lung tumor progression 
[65] 




efficiency compared to 
high MW chitosan 




C57BL/6 mice PEI and PEI-
PEG 
PEI-PEG formulations 








Chitosan Specific gene silencing 
effect against tumor cells 
[68] 




BALB/c mice *CPP (TAT and 
penetratin) 
No increase in gene knock 
down effect compared to 










Schematic illustrations of non-viral siRNA carriers are illustrated in Figure 1.2. As discussed 
later, nanocarriers can be chemically modified in a modular fashion to design multi-functional 
particles which unite therapeutic and diagnostic properties that are target specific.  
 
 
Figure  1.2: Schematic illustration of three classes of siRNA delivery systems; Polymer-, lipid-, 
or dendrimer-based vectors form complexes with negatively charged siRNA via electrostatic 
interaction. siRNA can be encapsulated in the core of the particle or attached to the particle 
surface. Multi-functional nanocarriers can be engineered with multiple components to unite 
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prevention. Discovering these new target genes will eventually open new opportunities for 
therapeutic siRNA delivery strategies. Pulmonary siRNA-based therapeutics are heading towards 
fulfilling therapeutic effects in the lung by exploiting smart delivery systems. The development 
of these systems requires a critical understanding of the numerous pulmonary barriers and 
stringent optimization of the carriers in order to achieve maximum results.  
Despite being a new field, reports on siRNA delivery in the literature increase steadily. 
Therapeutics based on siRNA technology have entered clinical trials. Their success in terms of 
safety and efficacy is currently being investigated at different stages. Many trials exploit local 
delivery, including inhaled or intranasally delivered siRNA (Table 1.2).  
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from basic research to clinical trials. In 1998, RNAi was discovered in C. elegans worms by Fire 
and Mello, for which they received the Nobel Prize in Physiology and Medicine in 2006.2 Small 
interfering RNA (siRNA) is an intermediate in the RNAi process and is double stranded RNA 
with 21-25 nucleotides in length. Synthetic siRNA can be used to achieve RNAi and to down-
regulate overexpressed genes.3 In 2001, siRNA was reported to induce RNAi in mammalian 
cells.4 To the present day, only a few human clinical trials for siRNA therapeutics are ongoing. 
Among which, two therapeutics are targeting the lung, i.e. ALN-RSV01 and ExcellairTM.5 
The primary challenge of siRNA therapeutics, however, is the hurdle of intracellular 
delivery. siRNA cannot cross a biological membrane due to being a hydrophilic, negatively 
charged macromolecule and highly prone to nuclease degradation.3b Viral vectors achieve high 
transduction but are associated with many safety problems at the clinical level such as immune 
responses and carcinogensis.6 Therefore, safe and effective non-viral siRNA carriers are required 
for pulmonary delivery of siRNA.7  






























































































limited endosomal escape despite their good proton-buffering capacity.11b It is hypothesized that 
the maximum interaction of siRNA with cations consists of four carbon-bridges. However the 
low molecular weight of spermine limits its siRNA complexation ability.12 Therefore, it was 
necessary that spermine polyamines be modified to increase their molecular weight in order to 
act as building blocks for nucleic acid delivery systems.11a, 13 This suggests that polymerized 
spermines could be capable of condensing siRNA and of disassembling at the target site.14 
Polyspermines showed high buffering capacity.15 Many studies described the linkage of 
spermines through their amino groups by different cleavable linkers such as disulfide bonds or 
esters.11a, 15-16 When polyspermines are degraded to release spermine monomers, sometimes 
fragments of the linker are still attached to spermine monomers which affects their transfection 
properties.17 Very recently, Du et al. compared three polymerized spermines to show that linkage 
structures play an important role in the activity of the polyspermine-based nucleic acid carriers.8b   
Moreover, spermine polymerization allows for multi-step intracellular degradation of a  
biocompatible polymeric platform.14. Several groups have studied spermine-based carriers for 
DNA,18 19 11a siRNA,11a, 20 and short RNA delivery.21 Gene silencing efficiency was shown 
specifically via aerosol delivery.21-22. Spermines have been incorporated in many delivery 
systems such as lipoplexes,20b, 23 conjugates,20a and nanoparticles24 for siRNA delivery to 
enhance the transfection efficiency. Vijayanathan et al. synthesized a series of spermine 
homologues with different methylene chain length separating the secondary amino groups of the 
polyamines. The lower homologues were more efficacious in DNA condensation than the higher 
analogues. These results showed the importance of the regiochemical distribution of the positive 
charge in the polyamines presented by the varying distance of the methylene spacing which 




















































































































































































obtained from BASF (Lupasol®, Cologne, Germany).  Dicer substrate double-stranded siRNA 
(DsiRNA) targeting firefly luciferase gene (FLUC siRNA, 25/27mer), human glyceraldehyde 3-
phosphate dehydrogenase (hGAPDH) gene, nonspecific control (siNegCon) DsiRNA as well as 
Alexa Fluor®-488 labeled siRNA were bought from Integrated DNA Technologies (IDT, 
Coralville, Iowa). RPMI-1640 medium (1x) with 2.05 mM L-glutamine, HyClone™ trypsin, 
penicillin/streptomycin, 4-(2(hydroxyethyl)-1-piperazine ethanesulfonic acid (HEPES), and 
SurePrep™ TrueTotal™ RNA purification kits were purchased from Thermo Fisher Scientific 
(Waltham, MA). Dulbecco's Phosphate Buffered Saline (PBS), Fetal Bovine Serum (FBS) Heat 
Inactivated, D-(+)-Glucose, sodium bicarbonate, sodium pyruvate, 2-mercaptoethanol, dimethyl 
sulfoxide Hybri-Max™ (DMSO, ≥99.7%), ethylenediaminetetraacetic acid (EDTA, 99.4%-
100.06%), trypan blue (0.4%, sterile filtered) and luciferin solution were bought from Sigma-
Aldrich (St. Louis, MO).  Hs_GAPDH_primers and Hs_β-actin-primers were purchased from 
Qiagen (Valencia, CA). Brilliant III SYBR Green QRT-PCR Master Mix was bought from 
Agilent (Santa Clara, CA). And DNAse I reaction buffer and DNase/RNase free water were 
purchased from ZYMO RESEARCH (Irvine, CA). 
2.3.2 Synthesis of Oligospermines 
Three different polycatonic-based oligospermines namely, linear bisspermines, linear 
tetraspermines and dendritic tetraspermines were successfully synthesized as described 
previously.26 Briefly. the process involved 1) the synthesis of the monomer I MPBBSP 
(monoprotected bis-boc spermine), 2) the synthesis of the reactive intermediates of 2-arm and 4-
arm linker, and 3) the conjugation of monomer I to the linkers to get respective protected 
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Where m is the mass of the polymer needed, (n) is the amount of siRNA used per well. The 
total number of nucleotides in DsiRNA is 52. N/P is the ratio between polymer amine groups and 
siRNA phosphate groups.   
Equal volumes of polymer and siRNA solutions were mixed to form the according N/P ratio, 
vortexed for 30 s and incubated at room temperature for 20 minutes. 
2.3.4 Size and zeta (ζ)-potential analysis 
Sizes of polyplexes were evaluated by Dynamic Light Scattering (DLS) analysis. 
Polyplexes were prepared with 40 pmol of FLUC siRNA at N/P 2 and 10 as described above in a 
total volume of 350 μl. Measurements were performed with a Malvern Zetasizer Nano ZS 
(Malvern Instruments Inc., Westborough, MA) in quadruplicates at 25 °C using disposable 
cuvettes (low volume 70 μl, Brookhaven Instruments Corporation, NY, USA) for size 
measurements. Measurements were set up at 173º backscatter angle with 15 runs per 
measurement. For data analysis, the viscosity (0.88 mPa.s) and the refractive index (1.33) of 
water at 25ºC were used. Results are given as Z average in nm +/- standard deviations. 
Polyplexes were then diluted to 700 μl with 5% glucose solution before ζ-potential 
measurements were performed in disposable capillary cells (Malvern Instruments Inc., 
Westborough, MA). Results are given in mV +/- standard deviations. 
2.3.5 Size and Morphology: Transmission Electron Microscopy (TEM) and Atomic Force 
Microscopy (AFM) 
For Transmission Electron Microscopy (TEM), polyplexes were prepared as described 





suspension was dispensed on a copper-coated grid (200-mesh) and left to dry before imaging 
with a transmission electron microscope (JEOL 2010 TEM). Several representative images were 
taken for each sample at different magnifications. Atomic force microscopy (AFM) was 
performed using a Pico LE Atomic Force Microscope (Molecular Imaging, Agilent 
Technologies, Santa Clara, CA). Polyplex suspensions were freshly prepared as described above. 
A drop was incubated on a freshly cleaved mica surface for 5 minutes and rinsed with deionized 
water to remove excess liquid. Samples were allowed to dry at room temperature and imaged in 
contact mode using a Si3Ni4 V-shaped cantilever.   
2.3.6  SiRNA condensation efficiency and stability against polyanions in neutral and 
acidic conditions: SYBR® gold dye binding assays and heparin competition assays  
SYBR® Gold assays were used to evaluate the capacity of the oligospermines to condense 
siRNA at various N/P ratios (0 to 20). SYBR® Gold dye intercalates only with free and 
accessible siRNA and does not fluoresce if the siRNA is condensed and protected by a 
polycation. In a FluoroNunc™ 96-well white polystyrene plate (Nunc, Thermo Fisher Scientific, 
Waltham, MA), 50 pmol of FLUC siRNA per well in 50 μl was complexed with the according 
amount of oligospermine  in the same volume to obtain the corresponding N/P ratios in a total 
volume of 100 μl of 5% glucose solution. PEI (5 kDa) was used for comparison. Formulations 
were incubated at room temperature for 20 minutes. A 4x SYBR® Gold solution (30 μl) was 
added to each well and incubated in the dark for 10 minutes. Fluorescence was measured at 495 
nm/537 nm excitation and emission wave lengths on a Synergy 2 Multi-Mode microplate reader 
(BioTek Instruments, Winooski, VT). For heparin assays, polyplexes were prepared at N/P 2 as 





compare the stability of the polyplexes at different pH and ionic strengths. The media were 5% 
glucose solution (pH 7.4) and sodium acetate buffer (pH 4.5). For the heparin assays, a master 
solution of heparin was prepared (0.1 IU/μL). Serial dilutions of heparin were then prepared (0-1 
IU/well) and added to the wells (10 μl/well). Subsequently, a 4x SYBR® Gold solution (30 
μl/well) was added and incubated for 10 minutes. After different incubation times with heparin 
(20 minutes, 1, 2 and 3 hours) at 25ºC, fluorescence was measured on a Synergy 2 Multi-Mode 
microplate reader (BioTek Instruments, Winooski, VT) at 495 nm/537 nm excitation and 
emission wave lengths. Measurements were performed in triplicates. The relative stability of 
polyplexes was determined by normalizing the fluorescence intensity of the intercalating 
SYBR® gold dye to SYBR® gold only (0%) and SYBR® gold with free siRNA (100%). Results 
are shown as mean values +/- standard deviation and analyzed by Graph Pad Prism5.0 software 
(GraphPad Software, La Jolla, USA).  
2.3.7 Cell culture 
NCI-H1299/LUC cells are derived from a human non-small cell lung carcinoma cell line 
(ATCC®) and transfected to stably expressing the reporter gene luciferase.27 H1299/LUC 
represents an established model for gene knock down studies as shown previously.27-28 Cells 
were cultured and grown in RPMI-1640 cell culture medium (Thermo Scientific Hyclone, 
Pittsburgh, PA) supplemented by sodium pyruvate (1 mM), HEPES (10 mM), 10% fetal bovine 
serum (Thermo Scientific Hyclone, Pittsburgh, PA), and 1% penicillin/streptomycin. Cells were 
grown in 75 cm2 cell culture flasks (Thermo Scientific, Waltham, MA) at 37 °C and 5% CO2 and 






2.3.8 Cytotoxicity of polyplexes: MTT assay    
H1299/LUC cells were seeded in a 96-well plate (Thermo Scientific, Waltham, MA) with 
10,000 cells per well in 100 μl of growth medium and incubated for 24 hours at 37 °C and 5% 
CO2 in a HERAcell 150i CO2 incubator (Thermo Scientific, Waltham, MA). Oligospermines 
with varying concentrations (2-1000 μg/ml) were added to the cells in fresh media and incubated 
for 24 hours at 37 °C and 5% CO2. Sterile filtered-MTT solution (5 mg/ml) was added to the 
cells (10 μl/well) and incubated for 4 hours at 37 °C and 5% CO2. Water-soluble MTT is 
enzymatically converted to insoluble formazan particles by metabolically active mitochondria.29 
Subsequently, the cell culture media was removed, and DMSO (200 μl/well, Sigma-Aldrich, St. 
Louis, MO) was added and incubated at room temperature for 10 minutes to solubilize the 
formazan particles. The optical absorbance was measured at 540 nm on a Synergy 2 Multi-Mode 
microplate reader (BioTek Instruments, Winooski, VT). The percentage of cell viability is 
measured as the ratio between the absorbance of a sample and the untreated control cells. Results 
are shown as the mean value +/- standard deviation of triplicates. 
2.3.9 Quantification of cellular uptake by flow cytomtery 
H1299/LUC cells were seeded in 24-well plate (Corning Incorporated, Corning, NY) with 
a density of 200,000 cells per well and incubated for 24 hours at 37 °C and 5% CO2. Polyplexes 
were freshly prepared as described above with 40 pmol of AlexaFluor488-labeled siRNA at N/P 
ratio 2 and 10. Negative controls included untreated control cells. PEI (5 kDa) was used as a 
positive control for comparison. Cells were transfected for 4 hours with 100 μl of cell culture 





500 μl, and cells were incubated for another 20 hours. Trypan blue quenching was used to 
extinguish the extracellular fluorescence caused by polyplex binding and to confirm the 
internalization of siRNA in the cells. Trypan blue 0.4% (100 μl per well), a dye that quenches the 
extracellular fluorescence,30 was added to the samples for 5 minutes before trypsinizing the cells. 
Results were compared to those obtained with cells that did not undergo trypan blue staining. 
Cells were rinsed with 1X PBS buffer supplemented with 2 mM EDTA, treated with trypsin and 
incubated at 37 °C and 5% CO2 for 3-4 minutes to detach the cells. Fresh medium (400 μl) was 
added to each well to deactivate the trypsin. Samples were transferred to microcentrifuge tubes 
(Seal-Rite, USA Scientific, Orlando, FL) and centrifuged at 400 g for 5 minutes. Samples were 
washed twice with 1X PBS with 2 mM EDTA. Fluorescence was quantified by flow cytometry 
on an LSR II (BD Biosciences, San Jose, CA) after staining with 4',6-diamidino-2-phenylindole 
(DAPI) for dead cells. Cell fluorescence was measured with excitation at 488 nm and the 
emission filter set to a 530/30 bandpass. Cell gating and data analysis was performed using 
FACSDiVa™ (BD Biosciences, San Jose, CA) software. Measurements were performed in 
triplicates; 10,000 viable cells each were gated and analyzed. Mean fluorescence intensity (MFI) 
results are given as the mean value of three independent measurements. Data analysis was 
performed by Graph Pad Prism5.0 software (GraphPad Software, La Jolla, CA).  
2.3.10 RNA knockdown measured by qRT-PCR  
In 6-well plates (Corning Incorporated, Corning, NY), H1299/LUC cells were seeded with 
a density of 500,000 cells per well and incubated for 24 hours at 37 °C and 5% CO2. Polyplexes 
were prepared with 200 pmol of hGAPDH siRNA at N/P 2 in a total volume of 100 μl and added 





transfection control. Cells were transfected with samples in fresh medium and incubated for 4 
hours. After 4 hours of incubation, medium was added to a total volume of 3 ml, and cells were 
allowed to incubate for an additional 20 hours. Subsequently, cells were washed with 1X PBS 
and lysed with lysis buffer (SurePrep TrueTotal™ RNA Purification Kit (Fisher BioReagents, 
Fisher Scientific, Waltham, MA). Total RNA was then isolated from cells according to the 
manufacturer’s protocol with supplementary DNase I digestion and reverse transcribed to cDNA 
and amplified in a one-step protocol using Brilliant III SYBR Green QRT-PCR Master Mix . 
Hs_GAPDH-primers primers were used to quantify the gene expression of hGAPDH. Hs_β-
actin-primers were employed as a standard to evaluate the relative gene expression of the two 
genes. Serial dilutions of total RNA of untreated cells were performed to plot calibration curves 
for GAPDH and β-actin mRNA levels.  Measurements were performed on a Stratagene Mx 
3005P (Agilent Technologies, Santa Clara, CA). Ct values were analyzed with the MxPro 
software (Mx 3005P version). Results were shown as mean values +/- standard deviation of 
triplicates and analyzed by Graph Pad Prism5.0 software (GraphPad Software, La Jolla, CA).  
2.3.11 Protein knockdown measured in reporter gene assays 
H1299/LUC cells were seeded at a density of 25,000 cells per well in a 24-well plates 
(Corning Incorporated, Corning, NY) and incubated at 37 °C and 5% CO2 for 24 hours before 
transfection. Cells were transfected with polyplexes with 40 pmol FLUC siRNA or nonspecific 
control DsiRNA at N/P 2 and allowed to incubate for 4 hours. Commercially available LF 
2000™ was used as a positive control. After 4 hours of incubation, medium was added to a total 
volume of 500 µl and allowed to incubate for an additional 44 hours. Cells were washed with 1X 
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whereas only a small portion of the secondary amines are  protonated.31 The linear tetraspermine 
has the highest number of secondary amines compared to the other two oligospermines 
suggesting the ability of this polymer to act as a “proton sponge” at the acidic pH of the endo-
lysosomal compartment.32 The structure of linear tetraspermines possesses multiple spermine 
units in a linear arrangement which enables cross-linking of single oligospermine molecules. 
Cross-linked polymers have been reported to better interact with negatively charged regions of 
nucleic acids and can therefore yield enhanced transfection efficiencies.33 
Dendritic structures are also very attractive as gene and drug delivery systems since they can be 
flexible structures with a multitude of end groups. The latter can be exploited to attach ligands, 
which opens various opportunities for cell-specific targeting. Due to their structure, dendrimers 
are believed to be more accessible for electrostatic interaction with RNA.34 In flexible 
dendrimers, the amines located within the inner structure are accessible for protonation which 
results in an increased “proton sponge effect”35 and consequently better transfection efficiency.34 
2.4.2 Size and zeta (ζ)-potential analysis 
To achieve efficient transfection, polyplexes must be well-characterized and reproducible. 
Many of the physico-chemical properties of polyplexes determine if they can overcome 
intracellular and extracellular barriers.36. Their size is an important factor for intracellular uptake 
and transfection. Some reports indicated that particles with a size below 150 nm are required for 
uptake in lung cells by endocytosis.37. However, other reports described that spermine-based 
delivery systems  with a larger size have good transfection efficiency in vivo and are suitable for 
lung cancer gene therapy.21a The ability of oligospermines to condense siRNA and form 





pmol of FLUC siRNA at N/P 2, 5, and 10 were compared in terms of hydrodynamic diameters 
and zeta-potentials. The change of size and zeta potential of polyplexes as a function of 
carrier/siRNA ratio was examined to determine a suitable N/P ratio for further investigations. All 
three oligospermines were able to condense siRNA into particles of sizes from 198.7 to 423.1 nm 
in diameter (Figure 2.4A). All polyplexes at N/P 5 were at least slightly larger than those at N/P 
2, which is in line with an earlier report that described N/P ratio dependent trends in sizes of 
siRNA polyplexes.38 Interestingly, both linear oligospermines showed an increase in size with 
increasing N/P ratios. Apparently, these polymers wrapped around the siRNA efficiently at an 
N/P ratio as low as 2 and then formed further layers of polymer on the surface of the polyplex. 
Another indication that supports this hypothesis is the increase of the zeta potential for the linear 
tetraspermine polyplexes with increasing N/P ratio (Figure 2.4B). Although linear 
bisspermine/siRNA polyplexes did not show a significant change in the zeta potential when 
increasing the N/P ratio, the zeta potentials of linear tetraspermine polyplexes increased from 1.5 
mV to 10.6 mV and 12.7 mV for N/P 2, 5, and 10, respectively. 
The dendritic tetraspermine, however formed polyplexes with decreased size at N/P 10 
(225.4 in diameter nm and 17.6 mV). This behavior can be explained by its intertwining structure 
that causes not all amines of the tetraspermine to be available for electrostatic interaction with 
siRNA at low N/P ratios. The comparably high zeta potentials these polyplexes bear also support 
the idea of positively charged dendrimer arms that are unable to be neutralized by the interaction 
with phosphates.39 However, these relatively high zeta potentials could possibly mediate 
cytotoxicity.40 Zeta potentials of dendritic tetraspermines polyplexes increased with increasing 





linear tetraspermine polyplexes were lower than that of the dendritic tetraspermine polyplexes at 
all of the tested N/P ratios (2, 5 and 10, Figure 2.4B).  
The surface charge of polyplexes is a significant factor for transfection efficiency of the 
polymer. Other studies have shown the ability of spermine-based polymers to neutralize the 
negative charge of nucleic acids to yield an overall neutralized to slightly positive charge suitable 
for interaction with the negatively charged cell membrane.13 In our study, all oligospermines 
polyplexes were positively charged (Figure 2.4B).  
Another prerequisite for successful and reproducible transfection, especially in vivo, is a 
narrow size distribution of the polyplexes 39. The polydispersity expressed as the polydispersity 
index (PDI) was low for polyplexes formed with the linear bisspermine (0.14<PDI< 0.3) 
compared to those formulated with the linear tetraspermine (0.26<PDI<0.34) and dendritic 
tetraspermine (0.22 <PDI<0.36, Table SI 1). The broader size distribution of the polyplexes 
obtained with the tetraspermines can be interpreted as a result of interaction between one longer 
polycationic polymer with more than one siRNA molecule, which can cause coalescence of the 
polyplexes.39 Many physical and biological parameters such as the molecular weight play an 
important role in determining the efficiency of a polymer to condense and deliver siRNA,.41. 
Linear tetraspermines (MW 2581.82) and dendritic tetraspermines (MW 2625.87) naturally have 
a higher molecular weight compared to linear bisspermines (MW 1299.40), which affects the 
ability of the polymers to interact with siRNA and to form polyplexes. As reflected by the size 
and zeta potential data shown in Figure 2.4, the structure of the polymer also plays a very 





Based on these results, the linear tetraspermine/siRNA polyplexes seemed to be the most 
favorable with the smallest size at N/P 2 (198.7± 22 nm) and a slightly positive zeta potential 
(1.54 mV). These characteristics are caused by (i) a favorable number of positively charged 
spermine units (4 units), and (ii) the linear structure which seems to be important for efficient 
interaction with siRNA and to yield a low positive close to neutral surface charge  that facilitates 
the crossing of the particle across the negatively charged cell membrane barrier. Polyplexes at 
N/P 2 with hydrodynamic diameters of 253.4± 26.3 nm for linear bisspermine polyplexes, 
198.7± 22 nm for linear tetraspermine polyplexes, and 311.5±18.5 nm for dendritic tetraspermine 
polyplexes were therefore selected for further experiments.  
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2.4.3 Size and morphology: Transmission Electron Microscopy (TEM) and Atomic Force 
Microscopy (AFM) 
The morphologies and sizes of the different polyplexes at N/P 2 were imaged by AFM 
(Figure 2.5). The sizes of the polyplexes estimated from the AFM images were 24-73 nm for 
linear bisspermine polyplexes, 101-348 nm for linear tetraspermine polyplexes, and 202-480 nm 
for polyplexes made with the dendritic tetraspermine. The differences between the sizes obtained 
by DLS compared to the AFM images can be explained by the different processes used to 
prepare the samples for DLS or AFM. The hydrodynamic diameters were determined in a 
suspension of the particles while the particles were dried for AFM. It is possible that polyplexes 
coalesced during the drying step. Additionally, the broad size distribution of the polyplexes 
shown by the imaging technique and confirmed by the polydispersity measurements (PDI) can 
explain why the Z average of the hydrodynamic diameters does not reflect the sizes measured by 
AFM. Most importantly, AFM images showed different morphologies of oligospermines 
polyplexes as a result of the different chemical architectures of the polymers used. Both linear 
oligospermines formed spherical particles, while the dendritic tetraspermine complexes show 
less defined morphology. These observations strengthen the hypothesis that linear 
oligospermines wrap around siRNA and condense it efficiently, whereas not all arms of the 
dendritic tetraspermine are involved in siRNA condensation, as shown in the fuzzy morphology 
of the polyplexes.  
TEM showed electron-dense areas in the polyplexes which could be the siRNA and the 
presence of very small particles (about 40 nm) in all polyplex formulations besides larger 
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reflected by increasing zeta potentials (Figure 1). With the rise of the zeta potential, the 
electrostatic interaction is enhanced, followed by higher condensation. All oligospermines were 
able to completely condense siRNA at N/P 2 and higher, whereas complete condensation of 
siRNA was only achieved at N/P 5 and higher for low molecular weight PEI. These results 
indicate that oligospermines tend to bind siRNA with higher affinity than PEI at low N/P ratios. 
Noticeably, linear bisspermine/siRNA polyplexes at N/P 2 showed relatively low condensation 
of siRNA compared to the other two oligospermines. This observation can be explained by the 
low molecular weight and short chain length of the bisspermine compared to the tetraspermines. 
The fact that the condensation efficiency did not increase for the bisspermine by increasing the 
N/P ratio additionally corroborates the observation of almost constant zeta potentials. Polyplexes 
with N/P 2 ratio were selected for further experiments based on their small size and overall good 
siRNA condensation. 












































































































against heparin competition, especially at low concentrations of heparin (Figure 4). It is 
important to note that the release profile from low molecular weight PEI complexes needs to be 
seen in the context of its poor condensation at N/P 2. As shown in Figure 3, at N/P 2, 75% of the 
siRNA is not yet condensed by 5 kDa PEI. It is not surprising, therefore, that the same amount of 
siRNA (75%) is found to be accessible for intercalation even in the absence of heparin. The 
remaining 25% of the siRNA are consequently very easily released from the complexes as shown 
in Figure 4.  
At neutral pH, less than 75% of the siRNA was released from the oligospermine complexes 
even at the highest heparin concentration (Figure 2.7A). Since a balance between complexation 
and decomplexation is necessary to release siRNA in the cytosol for efficient incorporation to the 
RNA induced silencing complex (RISC), the release profiles at lysosomal pH were tested also. 
At acidic pH, many amines, especially in PEI, which are not protonated at pH 7.4, were charged 
leading to an increase of the complexation efficiency. However, siRNA was easily released from 
PEI complexes at comparably low heparin concentrations at acidic pH also. In comparison, 
oligospermine complexes displayed better stability again. In the acidic environment, the 
tetraspermine complexes released comparable amounts of siRNA as PEI at high heparin 
concentrations. Only the bisspermine lacked efficient decomplexation properties.  
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polyplexes made of linear spermines, however, results in more quantitative competition with 
siRNA and thus release of the latter.  
2.4.5 Polymer cytotoxicity: MTT assay  
The formulation of non-viral vectors of cationic polymers and anionic nucleic acids is 
constrained by the compromise of high transfection efficiency which is often times only 
achieved at the price of high cytotoxicity.47 Using cationic polymers with high molecular weight 
and charge density can protect the resulting polyplex from destabilization by natural cellular 
polyanions. The trade off, however, is that these positive charges can interact with cell 
membranes, inhibit crucial biological processes and lead to cytotoxic effects. 40 MTT assays 
were therefore used here to evaluate the cytotoxic effect of three cationic oligospermine 
polymers on H1299/LUC cells after 24 hours of incubation with the polymers. Results are 
presented as percentage of cell viability compared to untreated control cells. As expected, the 
cytotoxicity of oligospermines increased with increasing polymer concentration. Moreover, 
increasing the cationic charge of the polymer by increasing the number of spermine moieties also 
increased the cytotoxicity. Linear tetraspermines and dendritic tetraspermines showed a higher 
toxicity at higher concentrations when compared to linear bisspermines. This trend is due to the 
presence of a higher number of positively charged groups at neutral pH in the linear 
tetraspermine (13 positively charged groups) and dendritic tetraspermine (14 positively charged 
groups) compared to linear bisspermine (7 positively charged groups). The dendritic 
tetraspermine polymer was even more toxic than the linear tetraspermine at high concentrations 
(0.5-1 mg/ml) which may be due to its structure. In conclusion, all oligospermines affected the 





LF 2000TM (IC50=41.41 µg/ml). At the corresponding polymer concentrations in polyplexes 
used in the following experiments, the cell viability was at least 83% after treatment with linear 
bisspermine, 88% with linear tetraspermine, and 77.3% with dendritic tetraspermine (Figure 2.8). 
It is important to note that the positive charge of the polymers is neutralized after polyplex 
formation with siRNA, so the viability shown here after treatment with polymer only is the 















Linear Tetraspermine ~ 6.648e-008














Figure  2.8. Cytotoxicity profiles of oligospermine polymers obtained by MTT assays. 
Percentages of cell viability of H1299/LUC cells are shown as a function of increasing polymer 
concentration after 24 hours of polymer incubation. The table shows the IC50 concentrations of 






2.4.6 Quantification of cellular uptake by flow cytomtery 
Cellular uptake was quantified by flow cytometry and compared to PEI (5 kDa) as a 
positive control and untreated cells as a negative control. Polyplexes with 40 pmol of 
AlexaFluor488-labeled siRNA at N/P 2 and 10 were compared. Additionally, trypan blue 0.4% 
was used on the cells to quench the extracellular fluorescence associated with polyplexes that 
bind to the surface but are not internalized. The results were compared to untreated cells. 
Overall, trypan blue-treated cells showed slightly lower mean fluorescence intensities compared 
to cells that did not undergo quenching of bound polyplexes. This indicates that a small fraction 
of the siRNA polyplexes were attached to the cell membrane but are not taken up intracellularly. 
Among the oligospermine polyplexes, the highest cellular uptake was achieved by polyplexes 
made of linear tetraspermine/AlexaFluor488-siRNA at N/P 2 (no trypan blue-treatment) (Figure 
2.9). These results are surprising because linear tetraspermine polyplexes were almost neutral at 
N/P 2 (1.54±0.5 mV), whereas dendritic tetraspermine polyplexes had a more cationic zeta 
potential (12±0.85 mV). For polymers such as PEI, an increase of the zeta potential which is 
obtained by increasing the N/P ratio is expected to mediate stronger siRNA delivery. This trend 
was confirmed here. However, PEI polyplexes at high N/P ratios are known to cause toxicity and 
off-target effects in transfected cells.48 While the siRNA delivery by oligospermine polyplexes 
was comparable to PEI at N/P 2, an increase of the N/P ratio to 10 did not increase their 
efficiency. Linear tetraspermine polyplexes at N/P 2 were found to have the smallest 
hydrodynamic diameters, however. It is possible that this parameter is favorable for uptake and 





oligospermine complexes compared to the fuzzy morphology of the dendritic tetraspermine 
polyplexes could have beneficially affected their internalization. 
 
Figure  2.9. Flow cytometry measurements showing the uptake of polyplexes made of 
AlexaFluor-488 labeled siRNA and linear bisspermine, linear or dendritic tetraspermine. Mean 
fluorescence intensities were quantified in H1299/LUC cells after 24 hours incubation with 
polyplexes prepared at N/P 2 and 10. Trypan blue treatment is performed to quench the 
extracellular binding of siRNA polyplexes to the cell. Cells treated with trypan blue showed 







































































































2.4.7 RNA knock down measured by qRT-PCR 
Real-time PCR was performed to quantify the knock down on the mRNA level mediated 
by polyplexes made of GADPH siRNA (200 pmol/well) and oligospermines at N/P 2. All 
oligospermines were used to form polyplexes with negative control siRNA (siNC) also. Linear 
bisspermine/siRNA polyplexes did not show gene silencing. This can be attributed to the 
incomplete siRNA release from the polyplex in the endo-lysolomal compartment as shown in 
Figure 4B. The most efficient oligospermine candidate was the linear tetraspermine, which is in 
line with the results of polyplexes size, zeta potentials, and flow cytometry. Linear tetraspermine 
polyplexes were shown to significantly downregulate the RNA expression more effectively than 
dendritic tetraspermines (54.6±17.3% vs. 75.1±1.5% residual GAPDH expression) (Figure 2.10). 
The dendritic structures showed less RNA knock down compared to the linear tetraspermine 
structure which could be explained by its less efficient uptake into the cells. In addition, the lack 
of secondary amines in the dendritic structure contributes to the lack of the “proton sponge 
effect”.35 Comparing the results of the three oligospermine polyplex formulations, we conclude 
that the difference in the architecture of the polymer strongly affected the efficiency of siRNA 
delivery to H1299/LUC cells. The linear tetraspermine structure is favored for successful siRNA 






Figure  2.10. Transfection efficiency in vitro (H1299/LUC cells) of polyplexes at N/P 2 on the 
mRNA level measured by qRT-PCR. Hs_GAPDH-primers were used to quantify hGAPDH gene 
expression. Hs_β-actin-primers were employed as a standard to evaluate the relative gene 
expression of the two genes. Polyplexes made of GADPH siRNA and linear tetraspermine 
showed the best knock down compared to dendritic tetraspermine (54.6% vs. 75.1% residual 






















































2.4.8 Protein knockdown measured in reporter gene assays 
At pH 4.5, the secondary amines are protonated leading to a strong buffering capacity 
inside the endosomes and thus a further influx of hydrochloric acid and water leading eventually 
to endosomal rupture. This event is believed to release endocytosed polyplexes and to support 
their endosomal escape into the cytosol.31 The silencing efficiency of the luciferase protein 
expression in H1299/LUC cells induced by oligospermines polyplexes at N/P 2 was evaluated 
after transfection with 40 pmol of anti-LUC siRNA after 48 hours of incubation. The results 
were normalized to the relative expression of untreated cells and compared to commercially 
available LF 2000™. LF was used in many studies as a positive control for siRNA mediated 
knock down efficiency.49 As in the mRNA knock down experiments, negative control siRNA 
(siNC) was also used with all oligospermines and LF. Linear tetraspermine/siRNA polyplexes 
showed the best knock down effect of luciferase expression compared to the other 2 
oligospermines (Figure 2.11), which is in agreement with the RT-PCR results. The dendritic 
tetraspermine and LF showed higher cytotoxic effects than the other polymers which can be 
explained by the cytotoxicity results shown in Figure 7. These results suggest that not only did 
the oligospermine architecture affect the interaction of the protonated portions of the polymer 
with the phosphate groups of siRNA, but these different siRNA complexation behaviors also 
lead to different efficiency of gene knock down. Linear bisspermine polyplexes were taken up by 
the cell but, showed neither knock down on the mRNA nor the protein level. This is attributed to 
the lack of amines in the short chain length and low molecular weight of the bisspermine 
structure which does not condense siRNA as quantitatively as the tetraspermines (Figure 2.3.) 





which Eliyahu et al. compared two chemically-modified spermine-based delivery systems for 
DNA delivery in terms of the number of spermine moieties and the distribution of charge density 
on the polymer backbone. In their study, a low and a high sperminated polymer were examined. 
The low sperminated polymer showed 56% less spermine per weight and 28% less primary 
amines than the high sperminated polymer. The low sperminated polymer was less efficient in 
neutralizing the negative groups of the nucleic acids and hence showed lower transfection 
efficiency compared to the high sperminated polymer.31 Another study of cationic spermine 
conjugates with different polysaccharides showed efficient in vitro transfection with high 
spermine content (2000 nmol/mg).31  In vivo experiments showed that chemically-modified 
dextran-spermine polyplexes successfully transfected mice with low toxicity and good 
tolerability when combined intramuscular and intranasal administration was performed.33, 50 
However, for efficient transfection, high positive zeta potential of the polyplex and large DNA 
doses were necessary.50 Dendritic structures have been described to be more accessible for 
electrostatic interaction with RNA.34 This is the case if the structurally inner amines are available 
for protonation which then also enhances the “proton sponge effect”,35 the endosomal escape, 
and the transfection efficiency.34 However, our results showed that the amines in short dendritic 
structure are not all available for interaction with siRNA. In comparison with short linear 
structures, short dendrimers are more rigid. The protonated amines in the dendritic structure were 
thus not neutralized which increased the cytotoxicity of the polyplexes. The polyplexes made 
with the dendritic structure did not show strong uptake or gene knock down efficiency which 
may be due to the larger sizes at N/P 2 compared to the other two polymers or the less spherical 
morphology. Therefore, the structural architecture of dendritic tetraspermine was associated with 
increased cytotoxicity and decreased transfection efficiency. 






















































































































decomplexation of siRNA and the carrier’s ability to escape the degradation in lysosomes are 
two main factors in determining the polymer’s transfection efficiency. The spatial availability of 
the positively charged amines in the polymer plays an important role for its electrostatic 
interaction with RNA and thus the shielding and protecting of siRNA. Therefore, the 
oligospermine architecture was shown to affect the transfection efficiency of polyplexes formed 
with siRNA. Consequently, an optimization of the used polymer is necessary. This can be 
achieved in many ways. Here, we investigated the effect of using different numbers of spermine 
monomers. In addition, we examined the effect of two different geometrical structures, namely 
linear and dendritic oligospermines. We found that tetramers of spermine are required to provide 
the adequate positive charge for both uptake and buffering effect for endosomal escape. From the 
comparison of linear bisspermines and linear tetraspermines, we found that increasing the 
number of spermines and charge density within the polymer enhanced the transfection efficiency 
at minimal toxicity. The linear structure is preferred over the dendritic structure, because the 
former seems to interact more efficiently with siRNA as not all amines of the latter are available 
for siRNA condensation leading to a more positively charged surface charge. Showing more 
efficient charge neutralization, the linear tetraspermine polyplexes are less cytotoxic and were 
shown to be more efficiently transfected into lung carcinoma cells (H1299/LUC). Therefore, we 
conclude that linear tetraspermines are very promising siRNA delivery systems. To enhance their 
intracellular uptake, coupling of targeting ligands is currently investigated.  
Supplementary Information contains polydispersity values, TEM images, and the temporal 
development of siRNA release at pH 4.5.  This material is available free of charge via the 
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Extensive reviews discussed the effects of surface nanotopography and bio-interfacial 
interaction, which is the interface between the cell and other fabricated material, on cell behavior 
in terms of motility [17], alignment [18], adhesion [19, 20], migration [21], differentiation [22], 
proliferation [23], nerve regeneration [24] and others  [25-29]. Much distinctive behaviour was 
observed for cells cultured on nanopatterns versus micro patterns, especially in anchorage-
dependant cells like neural cells including the dynamics of its membrane, elongation of axonal 
fibers to reach its specific targets, the growth pathway, and the cytoskeletal rearrangement that 
regulates the directional cell motility. Results vary according to the cell type, topography 
nanostructuctures and culture conditions [30]. The methodology applied for scaffold alignment 
also affects the alignment of cells with the nanotopography. Chaurey et al. described that 
fibroblasts oriented similarly on electrospun vs. nanoimprinted scaffolds for fiber larger than 100 
nm. However, cell alignment was more efficient on sub-100 nm nanoimprinted fibers [31]. The 
reason for these differences in cell behaviour is that many peptides which are  ECM components 
(such as laminin [32] and fibronectin) exist in nanoscale. Generally, nanopatterned structures on 
substrate surface were shown to induce cells to change morphology, alignment and adhesion 
compared to flat surfaces [33]. Dalby and coworkers cultured fibroblasts on 13 nm islands. 
Fibroblasts were found to have an increased cell attachment and spreading compared to a planar 
surface which were reflected by up-regulation of specific proliferative genes [33]. Later on, the 
same group used nanotopograhy as a non-invasive tool to understand the mechanism the 
mechano-transduction cascade of gene expression in fibroblasts [34].  
Wieringa et al. studied the effect of nanotopography effect on F11 a root-ganglion derived 





anisotropic topographic structures on the cell regarding the alignment and migration in the 
direction of the topographies [35]. F11 is an established model for studying cytoskeletal 
rearrangement, plasticity [36] and differentiation [37]. Wieringa et al. presented the F1 cell line 
as a potential peripheral sensory neuron model for nanotopographical guidance [38]. Substrates 
with two different ridge dimensions of 500 nm and 2000 nm and a constant groove width of 500 
nm were used to culture the cells. Another factor, the percentage of fetal bovine serum (FBS) in 
culture media was considered. In regards to the neurite guidance, no difference was shown 
between patterned and flat surface when cultured with 1% FBS. In contrast, when cells were 
cultured with 10% FBS, it was shown that the patterned surfaces induced the cell alignment with 
a trend of decreasing neurite alignment with increasing ridge width.    This supports the 
hypothesis that the cell alignment on nano-patterns occurs differently than on flat unpatterened 
surfaces and thus might influence the reliability of other aspects such as nerve regeneration. It 
also suggests that sometimes, a set of culture conditions can control the cell response rather than 
only one condition. A different report by Lee et al. describes osteoblast-like cells cultured on 
nano-thin polymer films on which nanopillar features were imprinted with a favourable size of 
200 nm. This process changed the contact angle of the thin film and the surface property from 
hydrophilic to hydrophobic. When cells were cultured on hydrophobic nanopillar surface, they 
showed poor spreading and adhesion, which might be due to the deprived adhesion on top of the 
nanopillars. This represents therefore a cell substrate model that resists the cell adhesion and 
spreading. Additionally, it was found that the most important factor in terms of the contact angle 
of the nanopillar with the plastic thin film is the temperature of imprinting and de-molding of the 
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low viscosity is deposited as drops by ink jet printing without spin coating.  The template is then 
lowered to a contact point with the resist. The resist flows to fill in the gaps between the 
substrate and the template topographies by the capillarity effect. Subsequently, UV irradiation is 
applied to cause polymerisation. The lowest possible pressure (<0.02 atm) among all other 
techniques is used in SFIL. The drop injection renders SFIL useful for patterning on non-planar 
surfaces [71]. Step and flash imprint lithography (SFIL)  is a good example for an optimised 
automated operation with reduced defects and contamination [72]. The alignment accuracy is 
about 10 nm [73]. Glangchai et al. used SFIL to form nanoparticles with uniform 50 nm size and 
shape using macromers. These nanoparticles are enzymatically-triggered to release an 
encapsulated drug. This novel incorporation of nanoimprinting represents a high-throughput 
technique with a precise control of the nanoparticles size. SFIL requires neither high temperature 
nor exposure of UV radiation for a long time. SFIL showed many advantages such as the high 
accuracy of alignment and uniformity. Besides, it can be used to imprint over a pre-patterned 
resist. This property suggests that SFIL can perform multi-layering of resists and form 3D 
scaffolds [74].   
Other developments have been studied to improve the conditions of NIL. The air cushion 
technique used to enhance the uniformity of the applied force was shown to increase the yield as 
well [75]. Other developments were the incorporation of a biological sample as a template in the 
process [76], reduction of temperature and pressure applied [77], polymerisation at room 
temperature [57], and others [78-83]. 

























































































ect ratio.  
















































































































g on the 
g and the lo
n uniformit


































































































e 3 [11]. T
 with a po
ature and p
e of the pa
ntrolled-on
ties, the a
ol of the re
perature a




r it. In conv




















y, in the re
 mould wit








































 The resist i
 off and tran
s for cell cu
sed as a ne
 of the mas
































llows for  
 nanoimprin
d resist is p
by thermal

















 of the po






used as a ce
and can he






























planarisation is characterised by the average peak-to-valley height of the coated resist. The 
solution used for spin-coating is the parameter that most strongly controls the thickness of the 
layer. By adjusting the degree of surface planarisation after spin-coating, pattern transfer can be 
accomplished in the inking and whole-layer transfer modes at temperatures and pressures as low 
as 30 °C below Tg and 1 MPa, respectively, which is significantly beneficial. At this lower 
temperature, the pattern transfer was found to be strongly dependant on the planarisation degree. 
If the polymer coating is non-planarised on the mould, the protruded areas only will be 
transferred to the substrate, resulting in so called inking pattern transfer. But if the polymer is 
planarised, then the entire polymer coat is transferred to the substrate which is called whole-layer 
transfer. The nature of these two modes only requires minimal dislocation of the polymer film 
which renders RNIL less prone to  polymer flow problems  [55].     
To reduce the high temperature and pressure requirements, Borzenko et al. modified the 
conventional NIL by applying the polymer bonding method. In this method, the polymer is 
applied on both the mould and the substrate to facilitate their bonding at reduced temperature and 
pressure. A specific treatment is used to leave the polymer on the substrate only after cooling. 
However, this method leaves a thick residue layer after the imprinting which complicates the 
subsequent transfer steps [99, 100]. 
• Reverse nanoimprint lithography (RNIL) is similar to T-NIL; however the thermoplastic 
resist is applied on the mould rather than the substrate. RNIL provides opportunities to use 
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(µCP) [102].  The formed nanopatterns were used to grow Hela cells. Results showed alignment, 
elongation as well as preferential localisation of cells at the nanolines formed. Another example 
for the combination of techniques is that of laser interference lithography (LIL) and UV-NIL. 
Although LIL is a simple, quick and easy method to fabricate nanopatterns, it has some 
limitations, namely the non-selectivity of produced patterns and difficulty of size restriction of 
maximum and minimum structures. On the other hand, fabricating master stamps by NIL is 
costly. In order to reduce the costs, LILL is used to fabricate the master stamp, subsequently, 
NIL is performed to form replicas used as cell substrates. Combining both techniques is 
advantageous to limit the non-selectivity of LIL as well [103]. Therefore, Lee et al. used LIL to 
fabricate a master stamp where a quartz wafer was coated with a photoresist of 1 μm thickness. 
Two series of laser exposures were performed at the interference state. The sample was rotated 
by 90 degrees before the second exposure. The photoresist was hard-baked to develop the 
patterns. These nano-patterns were then transferred by a reactive ion etching (RIE) process onto 
a quartz wafer coated with a Cr layer. At this point, a negative replica is produced.  A further 
RIE process was performed onto a quartz substrate to obtain a positive replica. The produced 
replicas are used as substrates for cell culture. Two patterns were obtained, i.e. a dense pattern 
and a scarce pattern. Patterns 1 and 2 are nanopillars round in shape, 123.3 and 130.1 nm in 
diameter, 200 and 500 nm in height, with an interval of 163.6 and 438.7 nm, respectively. The 
ratio percentage between pattern area and unit surface area of original flat surface was~14.5 for 
pattern 1 and ~4.1 for pattern 2. Human osteoblasts (hFOB1.19) were cultured on the two 
patterns as well as on a flat control surface. Cells on scarce patterns showed good adaptation to 
the pattern and filopodial extension with high directionality. Cells on dense patterns showed 





migration. The authors concluded that the contact guidance is dependent on the ratio of the 
pattern surface area to the pattern interval [104]. Rajput et al. recently used nanoholes with a 
gradient array of relative spacing ratios on a fused silica layer to form nanoneedles structures. 
Using nanoimprinting, the negative replica of the nanoholes was extracted by a polymer layer, on 
which silica was placed to form nano-needles. The pattern varied from 10 μm to 50 μm in one 
micron increments in both orthogonal directions in a spatial 2D gradient array. When fibroblasts 
were cultured on nanoneedles, an enhancement in cell adhesion was observed compared to flat 
silica surface which is due to the interaction between ECM components and nanoneedles, and 
prevention of cell aggregate formation [105].  
As described in the introduction, the mechanism of cell response to different nanopatterns had 
been poorly understood before the emerging of NIL. Cells cultured on hydrophobic nanopillar 
surfaces had shown poor spreading and adhesion [39]. Later, the role of the type of 
nanotopography in guidance and cell spreading was investigated in 2010 by Hu et al. The 
authors used nanoimprinting followed by demould-induced feature elongation to obtain 
nanopillar topographies with pillars larger than the mold depth. After seeding human foreskin 
fibroblasts on nanopillar topographies with 150 nm, ∼700 nm, or 1 μm in height, these cells also 
spread poorly on both the hydrophobic and hydrophilic nanopillar surfaces due to the restricted 
area at the tops of the pillars which did not suffice for the formation of micron-scale focal 
adhesions between the cells and the surfaces. The authors therefore suggested nanopillar 
topographies for surfaces on which cell spreading needs to be avoided [106].  
In a study by Xie at al., on the contrary, nanopillar arrays were used to pin the position of 





nanopillar dimensions were 150 nm in diameter, and 1 μm in height. However, Si and SiO2 
nanopillar substrates on platinum and quartz material were chosen for biocompatibility. After 
pinning the neurons to the nanopillars, the authors observed inhibited migration of the cell body. 
However, axons and dendrites were observed to freely grow and elongate into the surrounding 
area [107]. It becomes clear that on a similar nanotopography, different cell types can behave 
very differently, and that the substrate material plays an important role also.  
Another example for the fact that the combination of two parameters, rather than one [38], 
namely topography and culturing time, can significantly change the cellular alignment fibroblasts 
was reported by Loesberg et al. The authors determined the orientation angle of cells by 
measuring the angle between the direction of the grooves and the direction of cell growth which 
was determined by the maximum cell diameter to determine cell orientation. Loesberg et al. 
found that fibroblasts seeded on nanogrooved polystyrene (PS) substrates had aligned with the 
nanotopography of the substrates after only 4 h if the grooves were at least 100 nm wide and 75 
nm deep. Contact guidance reflected in fibroblasts orientation according to the grooves was even 
observed in only 35 nm deep grooves 24 h after cell seeding. The authors therefore concluded 
that the grove depth is the most determining parameter, although interdependence with culture 
time becomes obvious [108]. This is in contrast with a value reported by Dalby et al., who 
showed that lamellapodia and filopodia still show interaction with random nano islands as 
shallow as 10 nm [33].  
Nanotopographical substrates were also used to investigate nuclear deformation in human 
mesenchymal stem cells as it is known that nanoscale features can initiate cell-matrix adhesion 





therefore used a combination of soft lithography and T-NIL to obtain nanograted 
poly(dimethylsiloxan) (PDMS) and PS substrates which were coated with collagen for cell 
culture purposes. The authors were able to show by fluorescence microscopy and live cell 
imaging that nuclei of stem cells oriented and extended along the axis of the grating if grown for 
48 h on nanograted the PDMS or PS substrates. They also found that the mechanical properties 
of the substrate were an important parameter as shown by more rapid nuclei elongation on the 
stiffer PS substrates [109]. 
Johansson et al. also found that sympathetic and sensory ganglia cultured close to nano-
printed patterns in polymethylmethacrylate (PMMA)-covered silicon chips showed axonal 
outgrowth on ridge edges and elevations only tone week. The authors used electron beam 
lithography (EBL) and T-NIL to fabricate PMMA-covered silicon wafers and fast Fourier 
transform (FFT) analysis in order to quantify the alignment of the axonal outgrowth of ganglia. 
They described that axons were guided by nanoimprinted polymer patterns of at least 100 nm 
and concluded that the ratio of axon diameter and groove width was the major determinant 
affecting axonal guidance [110]. 
Crouch et al. directly imprinted tissue culture polystyrene (TCPS) with gratings of various 
pitches and depths using T-NIL after preparing their molds by UV contact photolithography and 
inductively coupled plasma (ICP) etching. To obtain 3D collagen-like structures with nano- and 
microstructures, they used double-imprinting. Human foreskin fibroblasts were seeded on the 
substrates and fixed 24 h later and found to align and elongate efficiently at increased aspect 





the cell behaviour, they also acknowledged that differences in cell types, culture conditions, and 
structure variation makes predictions difficult [111]. 
Although by far the most studies investigating cell guidance on nanotopographies have 
employed fibroblasts, other reports describe the growth of cells such as mesenchymal stem cells 
[109], neurons [107, 110, 112], astrocytes [113] or cardiac aorta endothelial cells [114] on 
nanoimprinted substrates. In a study investigating astrocyte reactivity, Ereifej et al. used UV-
NIL and pre-made reflective holographic-grated molds to obtain poly(methyl methacrylate) 
(PMMA) patterned substrates with either a period of 3600 grooves/mm or 1800 grooves/mm. 
The authors found that C6 rat astrocytoma cells seeded on the differently nanopatterened and 
non-patterened substrates showed less protein adsorption, less cell adhesion, proliferation, and 
viability if seeded on the 3600 nanopattern surface. They concluded that this particular 
nanopattern could be beneficial for the fabrication of neural electrodes to avoid glial scarring and 
astrogliosis after microelectrode implanation [113]. 
Similarly, Baranes et al. demonstrated that leech neurons growing on nano-scale line-
pattern ridges develop more simplified neuronal branching tree [112]. Their observations that 
small filopodia attach to the nano-ridges which guides the neuronal growth direction is in line 
with findings by Johansson et al. described above [110].  
In another example of neuronal cell culturing on nanoimprinted substrates, the impact of 
topographical noise, such as protein aggregates [115], and cellular debris [116], on the guided 
growth of neuritis was investigated. Tonazzini et al. used T-NIL to produce noisy nanogratings 





cell-dependant directionality were fabricated.  Differentiating neuronal PC12 cells were cultured 
on the patterned substrates, and observed for alignment and guidance. Results showed that the 
loss of neurite guidance is not linear to increasing the topographical noise. It is rather a threshold 
effect that is associated with the spatial arrangement and the focal adhesion (FA) maturation. 
Lastly, an antineoplastic drug, that promotes cell contractility, nocodazole, stimulated aligned 
FA maturation when incorporated in the scaffold and hence boosted the alignment. This suggests 
that using specific drugs can modulate the cell culture conditions and cellular growth on cell 
substrates [117].  
In 2009, Idota et al. used graft-polymerisation with an electron beam (EB) lithography 
system to fabricate temperature-responsive micrometer and nanometer-patterned poly(N-
isopropylacrylamide) (PIPAAm) layers with a 200 nm line-width. The authors found that 
fibroblasts and cardiac aorta endothelial cells growth was guided by the pattern orientation at 
temperatures above the lower critical solution temperature (LCST) but detached, shrunk and 
folded along the pattern below the LCST. It was concluded that this nano-scale system may 
allow engineering of functional 3D cell sheets or spheroids [114]. 
Table  3.1: Classification of nanoabrication methods in terms of type of energy sources. For each 
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In vivo, cells are exposed to physical directional cascade signals due to their  existence in a 
3D environment with certain topographical noise as discussed above [115, 116]. For example, 
cell guidance is also significantly altered if cells are cultured on a 3D scaffold with more than 
one type of cells. One example for cross-talk between two different filopodia populations was 
reported by Jang et al. The authors provided a 3D model to understand the guidance mechanism 
induced by artificial nanotopographies resembling ECM cues in neuronal cells. They used two 
different populations of filopodia at the growth cone. UV-NIL was used to fabricate arrays of 
parallel ridges (350 nm wide and 350 nm high, separated by grooves of 1, 2, 3, 5 times 350 nm 
width increments). Laminin, an ECM protein, was presented on a line nanopattern. The neurite 
outgrowth was shown to be oriented along the line pattern and the neurite length increased. 
Neurite outgrowth is a conventional behavior of the growth cone involving the two populations 
of the filopodia. The authors described the cross-talk between the two filopodia populations 
which regulated the sensing mechanism of nanotopographical stimuli. This cross-talk happens by 
the integration of the signals originating from the two populations but was not observed on a 
non-topographical substrate [134]. 
Three dimensional moulds can be used in NIL for direct 3D patterning. Li et al. used 3D 
moulds in a single-NIL-step. Moulds were fabricated by a single step electron beam lithography 
and reactive ion etching (RIE), then imprinted in polymer templates to yield three dimensional 
metal T-gates and air–bridge structures of sub 40 nm size [135]. The availability of 3D 
patterning stamps can allow for more opportunities and can reduce the cost of the process. 
Stamps are fabricated by various techniques, mostly electron beam techniques [136] [137], 





polymerisation [143, 144]. Other advances have developed to overcome the challenges of 3D 
mould fabrication [145, 146].  
Reverse nanoimprint can be used to construct multi-layer 3D nanostructures as described 
before [94]. Tavakkoli et al. used RNIL to fabricate a uniform nanostructured  discrete-track 
recording media  at a 50 nm track pitch in order to increase the current capacity of the magnetic 
hard disk recording media [147]. This study revealed even more advantages of RNIL over 
conventional NIL, such as the speed of the imprinting process, and a thinner residual layer.  
Multi-layered nanostructures can be built by layer-by-layer stacking of nanostructured 
layers via reverse nanoimprinting which does not require a planarisation layer and therefore is a 
desired technique. Multi-layering has recently been reviewed elsewhere [148, 149]. Multi-
layering by UV curable resists [150] avoids the formation of unfavourable residual layers and 
takes place at relatively low temperature and pressure compared to T-NIL. On the other hand, it 
is not easy to detach the cured structures which are used as templates later in the process. In 
distinction, thermally curable resists are easily detached, however one limitation to this technique 
is the relatively high temperature involved in the pattern transfer step near the glass transition 
temperature Tg of the resist which may cause the flowing and deformation of the bottom layer. 
To overcome this problem, two moulds with different silane treatment can be used to stack the 
two layers [151]. To overcome the high temperature limitation, Bao et al. used reverse thermal 
nanoimprinting with reduced Tg to stack three different polymers [94], however this 
methodology is limited in the type of polymers that can be used and in number of polymer layers 
that can be stacked. Therefore it was necessary to develop a technique to stack multilayers from 





Hu et al. used a simple NIL method to imprint 3D nanostructures on the widely used tissue 
culture polystyrene plates (TCPS). The process started by traditional NIL to imprint the first 
layer; however the second step was performed at a reduced temperature and pressure to avoid 
disturbance of the first layer. The second imprint was repeated for multiple layers to fabricate a 
3D scaffold with 350 nm to 10 µm gratings to study the effects of nano versus micro-patterns. 
Bovine pulmonary artery smooth cells (SMCs) were cultured on both patterns. Cell alignment 
and elongation was significantly higher in cells cultured on nano-patterns [152].  
Following a similar strategy, Yoshii et al. developed 3D nano-culture plates (NCPs) by 
imprinting into resinous inorganic sheets that were used to culture tumour cells.  Tumour cells 
grown on NCPs formed cell aggregates and attached to the nano-imprinted scaffold via the 
elongated lamellipodia. Consequently, these tumour cells produced multi-cellular spheroids 
which resemble in vivo tumour conditions. All these properties were lacking in cells grown on 
non-patterned scaffolds.  Also it was found that 17 genes were overexpressed in cells grown on 
NCPs, including hypoxia-induced factors target genes and genes relevant to intracellular 
interaction and multicellular organisation [153].  
Yew et al. used a single polymeric material to fabricate double and three-layer residual-
free nanostructures using reverse T-NIL [133]. A one dimensional grafting with ridges around 
250 nm width and 200 nm depth was transferred from the mould to the substrate in an orthogonal 
arrangement. Using a single material ensured avoiding another bonding material and the need for 
a planarisation layer. The stacking of the layers occurred at the Tg. On the other hand, some 





between them; however, by optimizing the fabrication conditions, such as the pressure, the 
compression can be avoided.  
Nakajima et al. fabricated multi–layers by applying a differential temperature between the 
lower layer (below Tg) and the upper layer (above Tg) [154]. Another recent technique, named 
reverse contact UV NIL, was developed by Kehagias et al. in 2007, which is a combination of 
nanoimprint lithography and contact printing lithography. The main purpose of combining these 
two techniques is to obtain 3D wood-pile like nanostructures and to transfer this pattern with no 
residual layers. This technique avoided the undesired etching processes that are typically 
necessary to remove the residual layer [155]. In 2013, Han et al. used RNIL to fabricate 3D 
nanostructures with a  UV curable resin and a resin of dispersed zinc oxide (ZnO) nanoparticles 
[131]. The UV-curable resin was transferred from a silicon stamp to a substrate as a 2D dual-
sided pattern layer. In this transfer step, a diluted UV-glue was used to increase the adhesion 
force between the pattern layer and the substrate without generating a thick residual layer. A 
ZnO dual side patterned layer was also fabricated. ZnO nanoparticles of 40 nm in size were used 
as a higher refractive index material to increase the photonic effect. After repeating these RNIL 
steps and stacking the 2D layers, a 3D structure was obtained. Haitainen et al. used T-NIL to 
linearly pattern micro gratings on top of nano pre-patterned structures [85]. Then step and stamp 
nanoimprint lithography (SSIL) was used to regulate the positioning and angle of the stamp 
rotation. 
Inclined nanoimprint lithography (INIL) is another technique used to develop 3D 
nanostructures in a single-imprinting step without the need to use a 3D template or multiple 






























































































the cost of 
























er to the in v
er pre-patte
orts in the li
 towards i












































































 in the desi
 substrate, s
abrication a












gn of cell su
ize of nanos
spects high





es to use n



































































rs such as th








































































 in diverse a
nd biochem















































s due to the


















































re options.  
utlook  
ecomes ob
, also the ch
With this r
 as well a








. To attain 
d here, whic

































































































 for cell cult
 the outcom





























materials, however, may also develop as more research is performed. So far, applications are still 
limited and very experimental, but an increase in model development, correlation of factors and 
results for a better prediction of successful models, as well as a strong increase in publications 
describing nanoimprinted cell and tissue culture models is expected. 
We believe research in this field is advancing in two main directions. The first one would 
be the optimisation of the polymer and scaffold properties. The second one could involve 
integrating more ECM components into the cell culture conditions, i.e. proteins, lipids, 
glucosamines, and others. Cells interact with ECM via transmembrane receptors called integrins 
which link the ECM to molecular complexes that bind to actin filaments [163]. Interactions 
mediated by integrins regulate cell adhesion, differentiation, migration and metastasis [164, 165]. 
Different integrins interact with different ECM ligands. The amino acid sequence RGD (Arg-
Gly-Asp) is the main adhesive site in the fibronectin binding region [165-167]. Including 
transmembrane ligands in cell culture substrates could augment our understanding of various 
ligand-receptor interactions as described by Schvartzman et al. Their study showed that 
spreading of mouse fibroblasts increased when at least four sites of ligands were placed within 
60 nm or less with no dependency on density [168]. Similar studies with nanoimprinted 
substrates including receptor proteins or ligands could give insights into interactions of cells with 
different receptors. Besides, 3D models would be a step towards mimicking the natural 
conditions of cell growth, but it is anticipated that research will move further towards a complete 
organ scaffold model. One example could be a lung model, designed and manufactured by 
nanoimprinting with detailed structures that can possibly be used in the future for transplantation 
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